| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_600db5b93a54999d3db277d10725d525 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 |
| filingDate |
1985-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1986-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f68083ee53d8671467af8b908e03e70e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_247272f3326d0f5b4b1f8abb9bd7fd30 |
| publicationDate |
1986-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4617306-A |
| titleOfInvention |
Pharmaceutical preparation comprising co-dergocrine and a calcium antagonist |
| abstract |
Pharmaceutical preparations comprising (a) co-dergocrine or a pharmaceutically acceptable acid addition salt thereof and (b) a calcium antagonist or a pharmaceutically acceptable salt thereof, as well as the treatment of hypertension/migraine by co-administration of components (a) and (b), e.g. in the form of a composition as defined. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6321767-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005049223-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6581634-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6209563-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4740365-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009166274-A1 |
| priorityDate |
1983-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |